CompaniesThe Binding Site

The Binding Site

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

80,911

By Phase

NA: 1

By Status

RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT03327597
Hover over trial bars to see details

Recent Trials

NCT06054373Collaborator
The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases
N/ARecruiting
150 participants
Started: Jul 27, 2023 · Completed: Sep 30, 2024
NCT03327597Collaborator
Iceland Screens, Treats or Prevents Multiple Myeloma
NAActive, not recruiting
80,761 participants
Started: Sep 1, 2016 · Completed: Sep 1, 2026
Related Companies
Thermo Fisher
acquired
The Binding Site | Biotech Hunter | Biotech Hunter